Yamasaki Hiroyuki, Takahashi Kayoko, Yamamoto Shunsuke, Yamamoto Yoko, Miyata Yoshihisa, Terai Takekazu
Department of Anesthesiology, Osaka City University Graduate School of Medicine, 1-5-7 Asahi-machi, Abeno, Osaka, 545-8586, Japan,
J Anesth. 2013 Dec;27(6):822-6. doi: 10.1007/s00540-013-1627-3. Epub 2013 May 7.
Although attenuation of tube-induced coughing is necessary in specific types of surgery, the best method for such attenuation is still unclear. We studied the combined intervention of endotracheal lidocaine and intravenous remifentanil compared to intravenous remifentanil alone with respect to coughing during emergence from anesthesia.
We examined 60 ASA 1-2 patients (age, 20-69 years) undergoing tympanoplasty under general anesthesia. Anesthesia was induced with propofol, remifentanil, and rocuronium. The trachea was intubated using a laryngotracheal instillation of topical anaesthetic (LITA) tracheal tube. Anesthesia was maintained with propofol and remifentanil (0.1-0.3 μg/kg/min). Propofol was discontinued and remifentanil (0.1 μg/kg/min) was continued at the end of the operation. Patients were randomly allocated to the lidocaine (n = 30) and control groups (n = 30). We administered 3 ml 4 % lidocaine via the LITA tube to patients in lidocaine group at the end of the operation. The trachea was extubated when the patient regained consciousness and followed orders. Coughing was evaluated using a 4-point scale by an observer who examined the video records at extubation.
Fewer patients in lidocaine group (8 of 30) than in control group (18 of 30, p < 0.01) coughed. Fewer patients in lidocaine group (2 of 30) than in control group (12 of 30, p < 0.01) had moderate or severe cough (scale 2 or 3).
This study is consistent with the finding that endotracheal lidocaine administration and continuous infusion of remifentanil before extubation is useful to prevent coughing on emergence from anesthesia.
尽管在特定类型的手术中减轻气管插管引起的咳嗽是必要的,但实现这种减轻的最佳方法仍不明确。我们研究了气管内利多卡因和静脉注射瑞芬太尼的联合干预与单独静脉注射瑞芬太尼相比,在麻醉苏醒期咳嗽方面的效果。
我们检查了60例年龄在20 - 69岁、美国麻醉医师协会(ASA)分级为1 - 2级、接受全身麻醉下鼓室成形术的患者。麻醉诱导采用丙泊酚、瑞芬太尼和罗库溴铵。使用喉气管滴注局部麻醉剂(LITA)气管导管进行气管插管。麻醉维持采用丙泊酚和瑞芬太尼(0.1 - 0.3μg/kg/min)。手术结束时停用丙泊酚,继续静脉输注瑞芬太尼(0.1μg/kg/min)。患者被随机分为利多卡因组(n = 30)和对照组(n = 30)。在手术结束时,我们通过LITA导管向利多卡因组患者给予3ml 4%的利多卡因。当患者恢复意识并能听从指令时进行气管拔管。由一名观察者通过检查拔管时的视频记录,使用4分制对咳嗽进行评估。
利多卡因组咳嗽的患者(30例中的8例)少于对照组(30例中的18例,p < 0.01)。利多卡因组中度或重度咳嗽(2级或3级)的患者(30例中的2例)少于对照组(30例中的12例,p < 0.01)。
本研究结果与以下发现一致,即在拔管前气管内给予利多卡因并持续输注瑞芬太尼有助于预防麻醉苏醒期的咳嗽。